— Know what they know.
Not Investment Advice

AMPE OTC

Ampio Pharmaceuticals, Inc.
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +3421.2% 1Y: +6681.5% 3Y: -95.4% 5Y: -100.0%
$0.18
+0.00 (+0.00%)
 
OTC · Healthcare · Biotechnology · Tech Score Neutral · Power 51 · $207884 mcap · 1M float · 0.0030% daily turnover · Short 46% of daily vol

Balance Sheet Trends

Total Assets
$6M -57.8% ▼
5Y CAGR: -16.4%
Total Liabilities
$2M +32.1% ▲
5Y CAGR: -23.0%
Shareholders Equity
$3M -71.5% ▼
5Y CAGR: -8.5%
Cash & Investments
$4M -67.7% ▼
5Y CAGR: -11.6%
Total Debt
$274K -65.9% ▼
Net Debt
-$4M +67.8% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2019FY2020FY2021FY2022FY2023
— Assets —
Cash$7M$17M$34M$13M$4M
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$7M$17M$34M$13M$4M
Net Receivables$18K$185K$16K$0$920K
Inventory$0$266K$72K$0$0
Other Current Assets$538K$696K$533K$642K$478K
Total Current Assets$8M$18M$36M$13M$6M
Property, Plant & Equip.$6M$4M$3M$259K$0
Goodwill & Intangibles$0$0$0$0$0
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets$0$0$0$0$136K
Total Non-Current Assets$6M$4M$3M$259K$136K
Total Assets$14M$23M$39M$14M$6M
— Liabilities —
Accounts Payable$151K$186K$427K$97K$750K
Short-Term Debt$259K$0$269K$189K$0
Deferred Revenue$0$0$0$0$0
Other Current Liabilities-$187K$0$120K-$46K$0
Total Current Liabilities$4M$2M$5M$1M$2M
Long-Term Debt$1M$0$0$0$0
Other Non-Current Liab.$854K$3M$6M$333K$0
Total Non-Current Liabilities$3M$4M$6M$607K$0
Total Liabilities$8M$5M$12M$2M$2M
— Equity —
Common Stock$16K$19K$23K$2K$0
Retained Earnings-$185M-$201M-$218M-$234M-$243M
Accumulated OCI$0-$0$0$0$0
Total Stockholders Equity$6M$18M$27M$12M$3M
Total Liabilities & Equity$14M$23M$39M$14M$6M
— Key Metrics —
Total Debt$1M$1M$1M$803K$274K
Net Debt-$5M-$16M-$33M-$12M-$4M
Total Investments$0$0$0$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms